Physician profile
Parag M Doshi
NPI 1578544334
$1,107.77
in general payments reported to CMS, 2019-2025
15 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $170 · 2021: $275 · 2022: $190 · 2024: $78.41 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $431.31 | 2019-2025 | Cardiomems, Esprit |
| Medtronic Vascular, INC. | $109.72 | 2019-2020 | |
| Boston Scientific Corporation | $81.63 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $74.89 | 2019-2020 | |
| Medtronic, INC. | $69.36 | 2021-2022 | |
| Angiodynamics, INC. | $62.23 | 2021 | |
| Philips North America LLC | $52.20 | 2019 | |
| Veryan Medical Incorporated | $43.10 | 2021-2022 | |
| Cordis US Corp. | $38.24 | 2022 | |
| Abiomed | $34.44 | 2025 | |
| Teleflex LLC | $30.68 | 2024 | Guideliner |
| Cleerly, INC. | $26.74 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Cardinal Health 200 LLC | $23.30 | 2020 | |
| Biotronik INC. | $15.11 | 2021 | |
| Coloplast Corp | $14.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parag Doshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.